Plant breeding dates back thousands of years to when people first domesticated wild plants. As the years have gone by, scientists’ understanding of agriculture has continued to progress. Adapting the basic principles that have been used for generations, plant breeding innovations like gene editing are preparing us to face 21st-century challenges. What could the future hold? Learn more at .
Innovation and Policy
Papers
Best Practices: Seed Industry Information-Sharing for Products of Gene Editing
Guide: Evaluation of Genome Edited Plants
Plant Breeding FAQs
Common Practices of Plant Breeders
An Overview of the Vegetable Seed Industry
Vegetable Success Stories
Plant Breeding: Meeting Agricultural Challenges
The U.S. Seed Industry at a Glance
Comments on Part 340
ASTA Statement on USDA’s Proposed Rule on Genetically Engineered Organisms
ASTA Comments to USDA’s Request for Information for Agriculture Innovation Agenda
Infographics
Safety of New Food Crops
Milestones in Plant Breeding
How Gene Editing Compares to Traditional Plant Breeding
Plant Breeders’ Response to Global Challenges
Videos
“Get to Know A Plant Breeder”
Plant Breeding Innovation in my Backyard
Dr. Richard Michelmore
Katelyn Fritz
Dr. Kent Bradford
Dr. Fred Gmitter
Fikret Isik
Devin Nichols
A joint project of the Biotechnology Innovation Organization (BIO) and ÑŲ©ÔÚÏßƽ̨ (ASTA), Innovature highlights progress in agriculture, food and wellness.
Agriculture and Science Support for International Statement on Agricultural Applications of Precision Biotechnology
The statement reiterates an international commitment to the fair, science-based treatment of agricultural innovation like gene editing, around the world.
This site covers global issues in biotechnology with links to key science and policy documents.
APHIS regulates certain GE organisms that may pose a risk to plant or animal health. In addition, APHIS participates in programs that use biotechnology to identify and control plant and animal pests.
The FDA page on Biotechnology – Genetically Engineered Plants for Food and Feed.
The EPA page on Plant Incorporated Protectants.
ISAAA is a not-for-profit international organization that shares the benefits of crop biotechnology to various stakeholders, particularly resource-poor farmers in developing countries, through knowledge sharing initiatives and the transfer and delivery of proprietary biotechnology applications.
The Biotechnology Industry Organization (BIO) is the world’s largest biotechnology trade association, providing advocacy, business development, and communications services for more than 1,100 members worldwide.
CropLife International’s page with information on plant biotechnology.
CERA’s purpose is to develop and apply sound science to the environmental risk assessment of agricultural biotechnologies so their contributions to sustainable production of food, fuel and fiber may be safely realized.
Beginning in 2010, the Biotechnology Industry Organization (BIO) and ÑŲ©ÔÚÏßƽ̨ (ASTA) and their members engaged key stakeholders to address the opportunities and the challenges associated with patent expiration. The result of this dialogue was the development of a framework, called the Accord, a private-sector driven mechanism that provides for the transition of regulatory and stewardship responsibilities for biotechnology events, after patent expiration.
The Advisory Committee is charged with examining the long-term impacts of biotechnology on the U.S. food and agriculture system and USDA, and providing guidance to USDA on pressing individual issues, identified by the Office of the Secretary, related to the application of biotechnology in agriculture. The AC21 is a broad-based committee representing a wide range of interests and agricultural expertise.
The International Seed Federation represents the interests of the mainstream of the seed industry at a global level through interaction and dialogue with public and private institutions that have an impact on international seed trade.
Ag Accord
Beginning in 2010, the Biotechnology Industry Organization (BIO) and ÑŲ©ÔÚÏßƽ̨ (ASTA) and their members engaged key stakeholders to address the opportunities and the challenges associated with patent expiration. The result of this dialogue was the development of a framework, called the Accord, a private-sector driven mechanism that provides for the transition of regulatory and stewardship responsibilities for biotechnology events, after patent expiration.
Visit for more information.
